Beatrice Belmonte
Beatrice Belmonte
Laboratorio di Immunologia dei tumori
Dirección de correo verificada de unipa.it
Título
Citado por
Citado por
Año
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection
S Petta, C Camma, VD Marco, FS Macaluso, M Maida, G Pizzolanti, ...
Liver International 31 (4), 507-515, 2011
1022011
WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer
L Castagnoli, V Cancila, SL Cordoba-Romero, S Faraci, G Talarico, ...
Oncogene 38 (21), 4047-4060, 2019
1002019
Pathogenic role of complement in antiphospholipid syndrome and therapeutic implications
F Tedesco, MO Borghi, M Gerosa, CB Chighizola, P Macor, PA Lonati, ...
Frontiers in immunology 9, 1388, 2018
352018
Cross-talk between myeloid-derived suppressor cells and mast cells mediates tumor-specific immunosuppression in prostate cancer
E Jachetti, V Cancila, A Rigoni, L Bongiovanni, B Cappetti, B Belmonte, ...
Cancer immunology research 6 (5), 552-565, 2018
342018
Complement protein C1q binds to hyaluronic acid in the malignant pleural mesothelioma microenvironment and promotes tumor growth
C Agostinis, R Vidergar, B Belmonte, A Mangogna, L Amadio, P Geri, ...
Frontiers in immunology 8, 1559, 2017
302017
New landscapes and horizons in hepatocellular carcinoma therapy
M Cervello, MR Emma, G Augello, A Cusimano, L Giannitrapani, M Soresi, ...
Aging (Albany NY) 12 (3), 3053, 2020
272020
Is the complement protein C1q a pro-or anti-tumorigenic factor? bioinformatics analysis involving human carcinomas
A Mangogna, C Agostinis, D Bonazza, B Belmonte, P Zacchi, G Zito, ...
Frontiers in immunology 10, 865, 2019
252019
Evaluation of thermoresponsive properties and biocompatibility of polybenzofulvene aggregates for leuprolide delivery
M Licciardi, G Amato, A Cappelli, M Paolino, G Giuliani, B Belmonte, ...
International journal of pharmaceutics 438 (1-2), 279-286, 2012
252012
Prognostic implications of the complement protein C1q in gliomas
A Mangogna, B Belmonte, C Agostinis, P Zacchi, DG Iacopino, ...
Frontiers in immunology 10, 2366, 2019
242019
Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma
G Augello, MR Emma, A Cusimano, A Azzolina, S Mongiovì, R Puleio, ...
International journal of cancer 144 (10), 2613-2624, 2019
222019
Pathological significance and prognostic value of surfactant protein D in cancer
A Mangogna, B Belmonte, C Agostinis, G Ricci, A Gulino, I Ferrara, ...
Frontiers in immunology 9, 1748, 2018
162018
Targeting COPZ1 non-oncogene addiction counteracts the viability of thyroid tumor cells
MC Anania, E Cetti, D Lecis, K Todoerti, A Gulino, G Mauro, T Di Marco, ...
Cancer letters 410, 201-211, 2017
152017
Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients
E Ferretti, S Hohaus, A Di Napoli, B Belmonte, A Cuccaro, E Cupelli, ...
Oncotarget 8 (49), 85263, 2017
152017
Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis
F Colombo, P Durigutto, L De Maso, S Biffi, B Belmonte, C Tripodo, ...
Journal of autoimmunity 103, 102288, 2019
142019
Biocompatibility and biodegradability of electrospun PHEA-PLA scaffolds: our preliminary experience in a murine animal model
AI Lo Monte, M Licciardi, M Bellavia, G Damiano, VD Palumbo, ...
Digest Journal of Nanomaterials and Biostructures 7 (2), 841-851, 2012
132012
The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer
L Forte, F Turdo, C Ghirelli, P Aiello, P Casalini, MV Iorio, E D’Ippolito, ...
BMC cancer 18 (1), 1-11, 2018
112018
CD10 and HHF35 actin in the differential diagnosis between Collagenous spherulosis and adenoid-cystic carcinoma of the breast
D Cabibi, AG Giannone, B Belmonte, F Aragona, F Aragona
Pathology-Research and Practice 208 (7), 405-409, 2012
112012
Cross-Talk between myeloid-derived suppressor cells and mast cells mediates tumor-specific immunosuppression in prostate cancer. Cancer Immunol Res.(2018) 6: 552–65. doi: 10 …
E Jachetti, V Cancila, A Rigoni, L Bongiovanni, B Cappetti, B Belmonte, ...
CIR-17-0385, 0
8
Gut microbiota condition the therapeutic efficacy of trastuzumab in HER2-positive breast cancer
M Di Modica, G Gargari, V Regondi, A Bonizzi, S Arioli, B Belmonte, ...
Cancer Research 81 (8), 2195-2206, 2021
72021
Glut-1 expression and in situ CD1a/CD57 immunologic deficit in keratoacanthoma and squamous cell carcinoma of immunocompetent patients
D Cabibi, F Aragona, C Guarnotta, V Rodolico, M Zerilli, B Belmonte, ...
Applied Immunohistochemistry & Molecular Morphology 19 (3), 239-245, 2011
72011
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20